Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT01472094
Eligibility Criteria:
Patients with Breast Cancer:
Inclusion Criteria:
* Patients with stages I-III breast cancer receiving adjuvant or neoadjuvant chemotherapy
* Able to understand English
* Able to provide informed consent
* Patients age ≥65 and of any performance status are eligible
Exclusion Criteria:
* Patients with metastatic disease
Breast Cancer Controls:
Inclusion Criteria:
* Patients with stages I-III breast cancer
* Patient will not receive adjuvant or neoadjuvant chemotherapy
* Patients age ≥65 and of any performance status are eligible
* Able to understand English
* Able to provide informed consent
Exclusion Criteria:
* Patients with metastatic disease
* Receipt of chemotherapy
Healthy Controls:
Inclusion Criteria:
* Patients age ≥65 and of any performance status are eligible
* No history of cancer (excluding non-melanoma skin cancer)
* Able to understand English
* Able to provide informed consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT01472094
Study Brief:
Protocol Section:
NCT01472094